Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104902) titled 'Study Comparing High Dose and Lower Dose Melphalan Before Stem Cell Transplant for Multiple Myeloma' on Feb. 26.
Study Type: Interventional
Study Design:
Other Method of generating randomization sequence:Permuted block randomization, variable Method of allocation concealment:On-site computer system Blinding and masking:Open Label
Primary Sponsor: ACTREC, Tata Memorial Centre
Condition:
Health Condition 1: C900- Multiple myeloma
Intervention:
Intervention1: Melphalan 140 mg/m2: Arm A Dose :140 mg/m2 Frequency: Single administration (one-time conditioning dose)
Route of Administration: Intravenous (...